Modified natural nanoparticles as contrast agents for medical imaging

被引:142
作者
Cormode, David P. [1 ]
Jarzyna, Peter A. [1 ]
Mulder, Willem J. M. [1 ]
Fayad, Zahi A. [1 ]
机构
[1] Mt Sinai Sch Med, Translat & Mol Imaging Inst, New York, NY 10029 USA
关键词
Nanoparticles; Contrast agents; Medical imaging; Lipoproteins; Viruses; MRI; HIGH-DENSITY-LIPOPROTEIN; MRI CONTRAST; IN-VIVO; VIRAL NANOPARTICLES; QUANTUM DOTS; ENHANCED MRI; ATHEROSCLEROTIC PLAQUES; NONINVASIVE DETECTION; LOADED APOFERRITIN; TARGETED DELIVERY;
D O I
10.1016/j.addr.2009.11.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The development of novel and effective contrast agents is one of the drivers of the ongoing improvement in medical imaging. Many of the new agents reported are nanoparticle-based. There are a variety of natural nanoparticles known, e.g. lipoproteins, viruses or ferritin. Natural nanoparticles have advantages as delivery platforms such as biodegradability. In addition, our understanding of natural nanoparticles is quite advanced, allowing their adaptation as contrast agents. They can be labeled with small molecules or ions such as Gd3+ to act as contrast agents for magnetic resonance imaging, F-18 to act as positron emission tomography contrast agents or fluorophores to act as contrast agents for fluorescence techniques. Additionally, inorganic nanoparticles such as iron oxide, gold nanoparticles or quantum dots can be incorporated to add further contrast functionality. Furthermore, these natural nanoparticle contrast agents can be re-routed from their natural targets via the attachment of targeting molecules. In this review, we discuss the various modified natural narroparticles that have been exploited as contrast agents. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:329 / 338
页数:10
相关论文
共 110 条
[1]   Identification of scavenger receptor SR-BI as a high density lipoprotein receptor [J].
Acton, S ;
Rigotti, A ;
Landschulz, KT ;
Xu, SZ ;
Hobbs, HH ;
Krieger, M .
SCIENCE, 1996, 271 (5248) :518-520
[2]  
Aime S, 2002, ANGEW CHEM INT EDIT, V41, P1017, DOI 10.1002/1521-3773(20020315)41:6<1017::AID-ANIE1017>3.0.CO
[3]  
2-P
[4]   Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents [J].
Allen, M ;
Bulte, JWM ;
Liepold, L ;
Basu, G ;
Zywicke, HA ;
Frank, JA ;
Young, M ;
Douglas, T .
MAGNETIC RESONANCE IN MEDICINE, 2005, 54 (04) :807-812
[5]   Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI [J].
Amirbekian, Vardan ;
Lipinski, Michael J. ;
Briley-Saebo, Karen C. ;
Amirbekian, Smbat ;
Aguinaldo, Juan Gilberto S. ;
Weinreb, David B. ;
Vucic, Esad ;
Frias, Juan C. ;
Hyafil, Fabien ;
Mani, Venkatesh ;
Fisher, Edward A. ;
Fayad, Zahi A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (03) :961-966
[6]   Viral nanoparticles donning a paramagnetic coat: Conjugation of MRI contrast agents to the MS2 capsid [J].
Anderson, Elizabeth A. ;
Isaacman, Steven ;
Peabody, David S. ;
Wang, Edwin Y. ;
Canary, James W. ;
Kirshenbaum, Kent .
NANO LETTERS, 2006, 6 (06) :1160-1164
[7]   From diagnostics to therapy: Prospects of quantum dots [J].
Azzazy, Hassan M. E. ;
Mansour, Mal M. H. ;
Kazinierczak, Steven C. .
CLINICAL BIOCHEMISTRY, 2007, 40 (13-14) :917-927
[8]   MR DIFFUSION TENSOR SPECTROSCOPY AND IMAGING [J].
BASSER, PJ ;
MATTIELLO, J ;
LEBIHAN, D .
BIOPHYSICAL JOURNAL, 1994, 66 (01) :259-267
[9]   MRI of the basement membrane using charged nanoparticles as contrast agents [J].
Bennett, Kevin M. ;
Zhou, Hua ;
Sumner, James P. ;
Dodd, Stephen J. ;
Bouraoud, Nadia ;
Doi, Kent ;
Star, Robert A. ;
Koretsky, Alan P. .
MAGNETIC RESONANCE IN MEDICINE, 2008, 60 (03) :564-574
[10]   Controlled aggregation of ferritin to modulate MRI relaxivity [J].
Bennett, Kevin M. ;
Shapiro, Erik M. ;
Sotak, Christopher H. ;
Koretsky, Alan P. .
BIOPHYSICAL JOURNAL, 2008, 95 (01) :342-351